Gene Expression Regulation, Leukemic
"Gene Expression Regulation, Leukemic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in leukemia.
| Descriptor ID |
D015973
|
| MeSH Number(s) |
G05.308.370.500
|
| Concept/Terms |
Gene Expression Regulation, Leukemic- Gene Expression Regulation, Leukemic
- Regulation of Gene Expression, Leukemic
- Regulation, Gene Expression, Leukemic
- Leukemic Gene Expression Regulation
|
Below are MeSH descriptors whose meaning is more general than "Gene Expression Regulation, Leukemic".
Below are MeSH descriptors whose meaning is more specific than "Gene Expression Regulation, Leukemic".
This graph shows the total number of publications written about "Gene Expression Regulation, Leukemic" by people in this website by year, and whether "Gene Expression Regulation, Leukemic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 1 | 3 |
| 1995 | 2 | 2 | 4 |
| 1996 | 5 | 1 | 6 |
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 2 | 3 |
| 2002 | 3 | 1 | 4 |
| 2003 | 0 | 2 | 2 |
| 2004 | 2 | 2 | 4 |
| 2005 | 4 | 1 | 5 |
| 2006 | 2 | 7 | 9 |
| 2007 | 2 | 5 | 7 |
| 2008 | 6 | 7 | 13 |
| 2009 | 7 | 6 | 13 |
| 2010 | 8 | 4 | 12 |
| 2011 | 9 | 9 | 18 |
| 2012 | 2 | 6 | 8 |
| 2013 | 3 | 10 | 13 |
| 2014 | 5 | 5 | 10 |
| 2015 | 3 | 9 | 12 |
| 2016 | 7 | 14 | 21 |
| 2017 | 4 | 9 | 13 |
| 2018 | 9 | 5 | 14 |
| 2019 | 2 | 8 | 10 |
| 2020 | 2 | 4 | 6 |
| 2021 | 2 | 4 | 6 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gene Expression Regulation, Leukemic" by people in Profiles.
-
MLL oncoprotein levels influence leukemia lineage identities. Nat Commun. 2024 Oct 29; 15(1):9341.
-
RNA sequestration in P-bodies sustains myeloid leukaemia. Nat Cell Biol. 2024 Oct; 26(10):1745-1758.
-
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia. Blood. 2024 08 01; 144(5):510-524.
-
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML. Nat Commun. 2024 Jun 04; 15(1):4739.
-
Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment. Nat Commun. 2024 May 01; 15(1):3681.
-
miRNA Biology in Chronic Lymphocytic Leukemia. Semin Hematol. 2024 Jun; 61(3):181-193.
-
CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells. Nat Commun. 2022 01 31; 13(1):587.
-
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c). Blood Cancer J. 2022 01 11; 12(1):5.
-
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia. Blood. 2021 11 11; 138(19):1885-1895.
-
RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences. Leukemia. 2022 03; 36(3):712-722.